Waning antibody levels and avidity: implications for MMR vaccine-induced protection (Q44263887)

1 December 2017

title

Waning antibody levels and avidity: implications for MMR vaccine-induced protection (English)

1 reference

1 December 2017

1 reference

Mia Kontio

1

1 reference

1 December 2017

Sari Jokinen

2

1 reference

1 December 2017

Mikko Paunio

3

1 reference

1 December 2017

Heikki Peltola

4

1 reference

1 December 2017

Irja Davidkin

5

1 reference

1 December 2017

language of work or name

English

0 references

publication date

10 September 2012

1 reference

Journal of Infectious Diseases

1 December 2017

published in

1 reference

1 December 2017

volume

206

1 reference

1 December 2017

issue

10

1 reference

1 December 2017

page(s)

1542-1548

1 reference

IgG avidity to distinguish secondary from primary measles vaccination failures: prospects for a more effective global measles elimination strategy

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS568

Secondary measles vaccine failures identified by measurement of IgG avidity: high occurrence among teenagers vaccinated at a young age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS568

Recent rubella virus infection indicated by a low avidity of specific IgG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS568

Humoral immune response after primary rubella virus infection and after vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS568

Assessment of IgM enzyme immunoassay and IgG avidity assay for distinguishing between primary and secondary immune response to rubella vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS568

The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS568

Measles, mumps, and rubella in Finland: 25 years of a nationwide elimination programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS568

Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS568

Persistence of rubella antibodies after 2 doses of measles-mumps-rubella vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS568

Antibody dynamics after tick-borne encephalitis and measles–mumps–rubella vaccination in children post early thymectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS568

The role of antibody concentration and avidity in antiviral protection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS568

Laboratory characterization of measles virus infection in previously vaccinated and unvaccinated individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS568

Two case studies of modified measles in vaccinated physicians exposed to primary measles cases: high risk of infection but low risk of transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS568

HIV-1 infection in Zambian children impairs the development and avidity maturation of measles virus-specific immunoglobulin G after vaccination and infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS568

Mumps outbreaks in vaccinated populations: are available mumps vaccines effective enough to prevent outbreaks?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS568

Symptomatic mumps virus reinfections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS568

Mumps virus reinfection is not a rare event confirmed by reverse transcription loop-mediated isothermal amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS568

Rubella: Reinfection of Vaccinated and Naturally Immune Persons Exposed in an Epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS568

Ongoing measles and rubella transmission in Georgia, 2004-05: implications for the national and regional elimination efforts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS568

Important parameters for evaluation of antibody avidity by immunosorbent assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS568

21 January 2018

Identifiers

DOI

10.1093/INFDIS/JIS568

1 reference

1 December 2017

1 reference